Table 1.

Clinical characteristics of COVID-19 patients (common, severe, and critical).

Groups	Total (n = 100)	Common group (n = 56)	Severe group (n = 28)	Critical group (n = 16)	P value∗,#
Age (Mean, SD)	44.6 ± 13.8	38.5 ± 12.4	45.2 ± 13.1	55.7 ± 14.6	<.001 <.001
Gender (n, %)
Male (n, %)	57 (57)	31 (55.4)	17 (60.7)	9 (56.3)	>.05 >.05
Contact history∗ (n, %)	100 (100)	56 (100)	28 (100)	16 (100)	>.05 >.05
Comorbidities (n, %)
Hypertension (n, %)	31 (31)	11 (19.6)	12 (42.8)	8 (50.0)	<.001 >.05
Cerebrovascular diseases (n, %)	8 (8)	2 (3.6)	3 (10.7)	3 (18.8)	<.001 <.001
Diabetes (n, %)	11 (11)	6 (10.7)	3 (10.7)	2 (12.5)	>.05 >.05
Coronary heart disease (n, %)	3 (3)	0	2 (7.1)	1 (6.3)	>.05 >.05
Chronic liver disease (n, %)	3 (3)	2 (3.6)	1 (3.6)	0	>.05 >.05
Chronic kidney disease (n, %)	2 (2)	1 (1.8)	1 (3.6)	0	>.05 >.05
Malignant tumor (n, %)	0	0	0	0	>.05 >.05
COPD (n, %)	2 (2)	1 (1.8)	1 (3.6)	0	>.05 >.05
1 Comorbidity (n, %)	29 (29)	9 (16.1)	13 (46.4)	7 (43.8)
2 Comorbidities (n, %)	8 (8)	4 (7.1)	3 (10.7)	1 (6.3)
≥3 Comorbidities (n, %)	5 (5)	2 (3.6)	2 (7.1)	1 (6.3)
Symptome (n, %)
Fever≥37. 3°C (n, %)	98 (98)	54 (96.4)	28 (100)	16 (100)	>.05 >.05
Cough (n, %)	71 (71)	40 (71.4)	20 (71.4)	11 (68.6)	>.05 >.05
Dyspnea (n, %)	62 (62)	35 (62.5)	17 (60.7)	10 (62.5)	>.05 >.05
Fatigue (n, %)	42 (42)	23 (41.1)	12 (42.3)	7 (43.8)	>.05 >.05
Headache (n, %)	9 (9)	5 (8.9)	3 (10.7)	1 (6.3)	>.05 >.05
Diarrhea (n, %)	17 (17)	10 (17.9)	5 (17.9)	2 (12.5)	>.05 >.05
Signs
Respiratory rate [median (IQR)]	20 (18–26)	20 (19–25)	21 (18–26)	22 (19–26)	>.05 >.05
Pulse [median (IQR)]	85 (78–93)	86 (79–94)	83 (74–95)	82 (73–96)	>.05 >.05
Systolic pressure (Mean, SD)	122.5 ± 13.8	120.1 ± 9.7	134.7 ± 16.2	136.7 ± 14.4	<.001 >.05
Diastolic pressure (Mean, SD)	76.5 ± 10.6	73.9 ± 8.8	86.1 ± 13.4	87.2 ± 11.2	<.001 >.05
Blood oxygen saturation [median (IQR)]	96 (92–98)	96 (95–98)	90 (88–94)	85 (80–91)	<.001 <.001